Nucleotide excision repair proteins rapidly accumulate but fail to persist in human XP-E (DDB2 mutant) cells

Area of Science:

• Molecular Biology
• Genetics
• Dermatology

Background:

• The xeroderma pigmentosum (XP-E) DNA damage binding protein (DDB2) plays a role in recognizing global genome DNA damage during nucleotide excision repair (NER).
• XP-E is a rare genetic disorder characterized by extreme sensitivity to sunlight and a high risk of skin cancer, often linked to mutations in DDB2.
• Understanding DDB2's precise function in NER is critical for comprehending XP-E pathogenesis and developing therapeutic strategies.

Purpose of the Study:

• To investigate the role of DDB2 in the DNA repair process following UV irradiation.
• To characterize the repair kinetics of different UV photoproducts (6-4PP and CPDs) in XP-E patient cells.
• To determine the impact of DDB2 mutations on the recruitment and persistence of NER proteins at DNA damage sites.

Main Methods:

• Cultured skin fibroblasts from newly identified XP-E patients with DDB2 mutations and healthy controls.
• Localized UV irradiation to induce DNA damage.
• Quantification of 6-4 photoproducts (6-4PP) and cyclobutane pyrimidine dimers (CPDs) repair.
• Immunofluorescence microscopy to track the colocalization and persistence of NER proteins (XPC, XPB, XPG, XPA, XPF) at UV-induced damage sites.

Main Results:

• XP-E fibroblasts exhibited slow repair of 6-4PP and markedly reduced repair of CPDs compared to normal cells.
• NER proteins rapidly colocalized to UV damage sites in both XP-E and normal cells within 0.1 hours.
• Unlike in normal cells where repair proteins persisted, they were undetectable at damage sites in XP-E cells within 0.5 hours.

Conclusions:

• DDB2 is not essential for the initial recruitment of NER proteins to UV photoproducts or for partial 6-4PP repair.
• DDB2 is critical for the sustained presence of NER proteins at DNA damage sites, which is necessary for efficient CPD removal.
• These findings highlight DDB2's essential role in maintaining the DNA repair machinery for complete nucleotide excision repair, particularly for CPDs, and offer insights into XP-E pathophysiology.